(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THE ALABAMA CENTER FOR CHILDHOOD CANCER AND BLOOD DISORDERS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

THE ALABAMA CENTER FOR CHILDHOOD CANCER AND BLOOD DISORDERS

ST13

US500000085487967

Class

44

Filing

85487967

Registration

4144496

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

08/10/2022

Trademark type

Word

Nice classes

44

Filing date

12/06/2011

Registration date

05/15/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/10/2022

Last transaction

08/10/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Supplemental Register

First use anywhere

09/01/2011

First use in commerce

09/01/2011

Drawing code

4

Owner type

03

Owner location

Birmingham, AL, US

Examiner

CARLYLE, SHAUNIA

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

T. A. (pessoa física)

Representatives

Michael S. Denniston BRADLEY ARANT BOULT CUMMINGS LLP

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

health care services and hospital services

Publications

History of USPTO decisions and trademark events.

16 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

08/10/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/10/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/10/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/02/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

02/15/2022

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

05/15/2021

NAS8

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

05/12/2018

8.OK

REGISTERED - SEC. 8 (6-YR) ACCEPTED

05/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

05/12/2018

ES8R

TEAS SECTION 8 RECEIVED

05/11/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/15/2017

R.SR

REGISTERED-SUPPLEMENTAL REGISTER

05/15/2012

CNTA

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

03/19/2012

DOCK

ASSIGNED TO EXAMINER

03/17/2012

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/12/2011

NWAP

NEW APPLICATION ENTERED

12/09/2011

Continuous trademark protection

Get notified about every new filing that threatens THE ALABAMA CENTER FOR CHILDHOOD CANCER AND BLOOD DISORDERS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.